BridgeBio Pharma LLC

Insider Reports History

Location
C/O Bridgebio Pharma, Inc., 3160 Porter Drive, Suite 250, Palo Alto, CA
Signature
/s/ Neil Kumar, Chief Executive Officer of BridgeBio Pharma LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BridgeBio Pharma LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. 10%+ Owner Common Stock 14.6M $167M $11.47 Oct 10, 2025 Direct

Insider Reports Filed by BridgeBio Pharma LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBOT BridgeBio Oncology Therapeutics, Inc. Oct 10, 2025 1 $0 4 Oct 16, 2025 10%+ Owner
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 0 $0 3 Aug 18, 2025 10%+ Owner